Long COVID’s Shadow: Could a New Wave of Alzheimer’s Be Brewing? Nearly one in five adults infected with COVID-19 develop Long COVID, and emerging research suggests the neurological consequences may extend far beyond fatigue and brain fog. Disturbingly, evidence is mounting that Long COVID isn’t just mimicking symptoms of neurodegenerative diseases like Alzheimer’s – it … Read more
The Hidden Costs of Heartburn Relief: How Long-Term PPI Use Could Reshape Preventative Healthcare Nearly 69 million adults in the United States experience heartburn at least once a week. While proton pump inhibitors (PPIs) like omeprazole and lansoprazole offer rapid relief, a growing body of evidence suggests a significant, often overlooked consequence: long-term use can … Read more
The boundaries of respiratory care have been dramatically redefined. A recent case study, published in Med, details the successful use of a novel total artificial lung (TAL) system to keep a patient alive after a complete bilateral pneumonectomy – the removal of both lungs – paving the way for a life-saving transplant. This isn’t simply … Read more
The relentless search for the root causes of multiple sclerosis (MS) has taken a significant turn, with new research from UCSF pointing to a potentially crucial role for the Epstein-Barr virus (EBV) and a specific type of immune cell. This isn’t simply confirming EBV’s presence – long known to be nearly universal in MS patients … Read more
Nearly one million Americans will be diagnosed with Parkinson’s disease by 2030. But what if we could shift from reactive treatment to proactive prevention? Emerging research suggests we can. Scientists are now pinpointing subtle genetic signals in blood samples that can predict an individual’s risk of developing Parkinson’s disease years, even decades, before the onset … Read more
The already vulnerable period of pregnancy and postpartum is now revealed to be a time of significantly heightened stroke risk for women with a prior history of ischemic stroke – more than doubling their chances of experiencing another event. This finding, presented at the American Stroke Association’s International Stroke Conference 2026, isn’t merely a statistical … Read more
The Silent Threat: Why Men’s Heart Disease Risk is Accelerating – and What’s Next Nearly 1 in 3 deaths in the United States are attributed to cardiovascular disease, but a recent wave of studies is revealing a disturbing trend: the onset of heart disease in men is happening decades earlier than previously understood. While conventional … Read more
Endometriosis, a condition affecting up to 10% of women of reproductive age, is notorious for its delayed diagnosis – often taking over a decade from the onset of symptoms to confirmation. This isn’t due to a lack of effort, but a fundamental challenge in early detection. Now, a new study published in Scientific Reports offers … Read more
Nearly 9% of US adults live with gout, a painful inflammatory arthritis often dismissed as a lifestyle ailment. But a growing body of evidence, recently reinforced by studies from Nottingham University and others, suggests this condition is a critical – and often overlooked – indicator of systemic cardiovascular risk. More importantly, existing treatments for gout … Read more
The landscape of stroke care is undergoing a rapid evolution, and the American Stroke Association’s newly released 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke reflects this seismic shift. This isn’t merely an update; it’s a recalibration of best practices driven by a decade of breakthrough trials and a growing urgency … Read more